×

Biotech earnings: All eyes on Gilead

3:45 PM ET Tue, 22 April 2014

CNBC's Meg Tirrell previews the earnings of biotech players Gilead and Amgen. Tirrell explains why investors will be focusing on Gilead's Sovaldi sales.